{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:13:30Z","timestamp":1783977210415,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07059-0","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:34:57Z","timestamp":1778556897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factor VII Padua: a systematic review of reported cases, diagnosis, clinical manifestations, and management strategies"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-1413","authenticated-orcid":false,"given":"Seyed Mehrab","family":"Safdari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-5357","authenticated-orcid":false,"given":"Mahmood","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-7329","authenticated-orcid":false,"given":"Samin","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-9319","authenticated-orcid":false,"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"6","key":"7059_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1172\/JCI102477","volume":"30","author":"B Alexander","year":"1951","unstructured":"Alexander B, Goldstein R, Landwehr G, Cook C, Addelson E, Wilson C (1951) Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Investig 30(6):596\u2013608","journal-title":"J Clin Investig"},{"key":"7059_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-319-76723-9_10","volume-title":"Congenital Bleeding Disorders: Diagnosis and Management","author":"M Shams","year":"2018","unstructured":"Shams M, Dorgalaleh A (2018) Congenital factor VII deficiency. Congenital Bleeding Disorders: Diagnosis and Management. Springer, pp 239\u2013259"},{"key":"7059_CR3","doi-asserted-by":"crossref","unstructured":"Herrmann FH et al (2009) Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene, Haemophilia.\u00a015(1): 267\u2013280","DOI":"10.1111\/j.1365-2516.2008.01910.x"},{"key":"7059_CR4","doi-asserted-by":"crossref","unstructured":"Shams M (2023) Congenital factor VII deficiency, diagnosis, and management. Congenital Bleeding Disorders: Diagnosis and Management. Springer, pp 259\u2013285","DOI":"10.1007\/978-3-031-43156-2_11"},{"key":"7059_CR5","doi-asserted-by":"crossref","unstructured":"Peyvandi F, BOLTON-MAGGS PH, Batorova A, De Moerloose P (2012) Rare bleeding disorders, Haemophilia.18:148\u2013153","DOI":"10.1111\/j.1365-2516.2012.02841.x"},{"issue":"4","key":"7059_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jcm6040038","volume":"6","author":"M Napolitano","year":"2017","unstructured":"Napolitano M, Siragusa S, Mariani G (2017) Factor VII deficiency: clinical phenotype, genotype and therapy. J Clin Med 6(4):38","journal-title":"J Clin Med"},{"key":"7059_CR7","doi-asserted-by":"crossref","unstructured":"Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F (2011) Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes, Hematology, 16(5):308\u2013312","DOI":"10.1179\/102453311X13085644680069"},{"issue":"7","key":"7059_CR8","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/humu.24025","volume":"41","author":"M Giansily-Blaizot","year":"2020","unstructured":"Giansily-Blaizot M et al (2020) The EAHAD blood coagulation factor VII variant database. Hum Mutat 41(7):1209\u20131219","journal-title":"Hum Mutat"},{"issue":"3","key":"7059_CR9","first-page":"387","volume":"91","author":"A Girolami","year":"1978","unstructured":"Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A (1978) Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 91(3):387\u2013395","journal-title":"J Lab Clin Med"},{"issue":"3","key":"7059_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00001721-199306000-00015","volume":"4","author":"A Girolami","year":"1993","unstructured":"Girolami A, Sartori M, Steffan A, Fadin M (1993) Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. Blood Coagul Fibrinolysis 4(3):497\u2013498","journal-title":"Blood Coagul Fibrinolysis"},{"key":"7059_CR11","doi-asserted-by":"publisher","unstructured":"Shams M, Hassani S, Dorgalaleh A, Zamani F, Ahmadi A (2023) Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients, (in eng), Blood Coagul Fibrinolysis.\u00a034(3): 156\u2013160, Apr 1 https:\/\/doi.org\/10.1097\/mbc.0000000000001195","DOI":"10.1097\/mbc.0000000000001195"},{"issue":"1","key":"7059_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1309\/36HQ36ETU7K8MUXT","volume":"126","author":"ES Pollak","year":"2006","unstructured":"Pollak ES, Russell TT, Ptashkin B, Smith-Whitley K, Camire RM, Bauer KA (2006) Asymptomatic factor VII deficiency in African Americans. American J Clin Pathol Article vol 126(1):128\u2013132. https:\/\/doi.org\/10.1309\/36HQ36ETU7K8MUXT","journal-title":"American J Clin Pathol Article vol"},{"key":"7059_CR13","doi-asserted-by":"crossref","unstructured":"Girolami A, Cosi E, Ferrari S, Girolami B, Randi ML (2019) Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery, Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders), 19(3): 233\u2013238","DOI":"10.2174\/1871529X19666190308114842"},{"key":"7059_CR14","doi-asserted-by":"crossref","unstructured":"Triplett DA, Brandt JT, Batard M, Dixon J, Fair DS (1985) Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis","DOI":"10.1182\/blood.V66.6.1284.1284"},{"key":"7059_CR15","doi-asserted-by":"crossref","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, Bmj. 372","DOI":"10.1136\/bmj.n71"},{"key":"7059_CR16","unstructured":"Safdari SM, Barati M, Hosseini S, Kalantar E, Zaker F, Dorgalaleh A Factor VII Padua in Iran: A Study on 150 Patients With Factor VII Deficiency, Haemophilia: the official journal of the World Federation of Hemophilia"},{"key":"7059_CR17","unstructured":"Sabharwal A et al (1992) Factor-VII deficiency (FVII (Richmond), R304Q mutant) associated with thrombosis, in Circulation, vol. 86, no. 4: AMER HEART ASSOC 7272 Greenville avenue, Dallas, TX 75231\u2009\u2013\u20094596, pp. 679\u2013679"},{"key":"7059_CR18","unstructured":"Shurafa M, Kumar A, Fair D, James H (1993) The molecular defect in factor-VII (Detroit) is due to substitution of Arg (304) by Gln, in FASEB Journal. Federation Amer SOC EXP BIOL 9650 RockvillE Pike, Bethesda, MD 20814\u2009\u2013\u20093998 USA, 7(3): A115-A115"},{"key":"7059_CR19","doi-asserted-by":"publisher","unstructured":"Kirkel D et al (2010) Asymptomatic factor VII deficiency: gene analysis and structure-function relationships, (in eng), Blood Coagul Fibrinolysis. 21(1):91\u2009\u2013\u200994\u00a0https:\/\/doi.org\/10.1097\/MBC.0b013e328331e708","DOI":"10.1097\/MBC.0b013e328331e708"},{"key":"7059_CR20","doi-asserted-by":"crossref","unstructured":"Peyvandi F, Mannucci P, Asti D, Abdoullahi M, Rocco ND, Sharifian R (1997) Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency, Haemophilia, 3(4):242\u2013246","DOI":"10.1046\/j.1365-2516.1997.00137.x"},{"key":"7059_CR21","doi-asserted-by":"crossref","unstructured":"Marty S et al (2008) The paradoxical association between inherited factor VII deficiency and venous thrombosis, Haemophilia, 14(3):564\u2013570","DOI":"10.1111\/j.1365-2516.2007.01647.x"},{"key":"7059_CR22","doi-asserted-by":"publisher","unstructured":"Marchetti G et al (Jul 1992) Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7), (in eng). Hum Genet 89(5):497\u2013502. https:\/\/doi.org\/10.1007\/bf00219173","DOI":"10.1007\/bf00219173"},{"key":"7059_CR23","doi-asserted-by":"publisher","unstructured":"Croze M, Brizard CP (1982) Factor VII Padua 1. Another case, (in eng), Haemostasis,\u00a011(3):185-8. https:\/\/doi.org\/10.1159\/000214660","DOI":"10.1159\/000214660"},{"key":"7059_CR24","doi-asserted-by":"publisher","unstructured":"Girolami A, Gaio A, Doglioni L, Procidano M, Saltarin P (1982) Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley, (in eng), Blut. 44(6): 363-9\u00a0https:\/\/doi.org\/10.1007\/bf00319920","DOI":"10.1007\/bf00319920"},{"key":"7059_CR25","doi-asserted-by":"publisher","unstructured":"Rabelo FY et al (2015) The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort, (in eng), Haemophilia.\u00a021(5): 670\u2009\u2013\u200980\u00a0https:\/\/doi.org\/10.1111\/hae.12645","DOI":"10.1111\/hae.12645"},{"key":"7059_CR26","doi-asserted-by":"crossref","unstructured":"O\u2019Brien DP et al (1991) Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male,","DOI":"10.1182\/blood.V78.1.132.132"},{"key":"7059_CR27","unstructured":"Takamiya MI, Kemhell-Cook O, Tuddenham G (1993) E:, Disfunctional human FVII variants and single-strand conformational polymorphism (SSC5) (abstract). Thromb Hemost. 69(suppl):1291"},{"issue":"2","key":"7059_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.ejhg.5200593","volume":"9","author":"M Giansily-Blaizot","year":"2001","unstructured":"Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved J-F (2001) Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 9(2):105\u2013112","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"7059_CR29","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/j.1538-7836.2004.00921.x","volume":"2","author":"Y Fromovich-Amit","year":"2004","unstructured":"Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U (2004) Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2(10):1774\u20131781","journal-title":"J Thromb Haemost"},{"issue":"5","key":"7059_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/01.mbc.0000172696.62363.8c","volume":"16","author":"Y Fromovich-Amit","year":"2005","unstructured":"Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa J-P, Seligsohn U (2005) Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 16(5):369\u2013374","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"7059_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-1596-7-92","volume":"7","author":"H Elmahmoudi","year":"2012","unstructured":"Elmahmoudi H et al (2012) Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia. Diagn Pathol 7(1):1\u20135","journal-title":"Diagn Pathol"},{"key":"7059_CR32","unstructured":"Tahatahary A, Ravanbod S, Baghaipour M, Enayar M, Ala F (2007) Rastager-Iari: Factor VII genotype and clinical profile in 6 Iranian patients with congenital factor VII deficiency. J Thromb Hemost, 5"},{"issue":"1","key":"7059_CR33","first-page":"1","volume":"1","author":"G Antonio","year":"2016","unstructured":"Antonio G, Mirta A, Emanuel S, Graciela S, Silvia F, Maria LA (2016) First report of homozygous factor VII Padua (Arg304Gln) defect in a family from Argentina. Res Artic Hematol Med Oncol Hematol Med Oncol 1(1):1\u20135","journal-title":"Res Artic Hematol Med Oncol Hematol Med Oncol"},{"issue":"1","key":"7059_CR34","first-page":"1","volume":"3","author":"A Girolami","year":"2018","unstructured":"Girolami A, Sueldo E, Ferrari S, Guerrero G, Cosi E, Arias M (2018) Report of the Second Patient with a Homozygous FVII Padua (Arg304GIn) Defect in Northern Argentina. Mathews J Case Rep 3(1):1\u20133","journal-title":"Mathews J Case Rep"},{"issue":"2","key":"7059_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/bjmg-2017-0027","volume":"20","author":"S Shahbazi","year":"2017","unstructured":"Shahbazi S, Mahdian R, Karimi K, Mashayekhi A (2017) Molecular characterization of Iranian patients with inherited coagulation factor VII deficiency. Balkan J Med Genet 20(2):19\u201325","journal-title":"Balkan J Med Genet"},{"key":"7059_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/HMO.1000204","volume":"5","author":"A Girolami","year":"2020","unstructured":"Girolami A, Farhat M, Hayward C, Ferrari S, Rossi E (2020) Arg304Gln (FVII Padua) coagulation disorder in a patient with Down Syndrome (trisomy 21): a remarkable observation from Argentina. Hematol Med Oncol 5:1\u20135","journal-title":"Hematol Med Oncol"},{"issue":"3","key":"7059_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01.mbc.0000061294.28953.42","volume":"14","author":"DN Rodrigues","year":"2003","unstructured":"Rodrigues DN, Siqueira LH, Galizoni AM, Arruda VR, Annichino-Bizzacchi JM (2003) Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Blood Coagul Fibrinolysis 14(3):289\u2013292","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"7059_CR38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1365-2141.1994.tb04793.x","volume":"86","author":"F Bernardi","year":"1994","unstructured":"Bernardi F et al (1994) Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 86(3):610\u2013618","journal-title":"Br J Haematol"},{"key":"7059_CR39","unstructured":"Horellou M, Chalendard J, Juin F, Conard J, Gouault-Heilmann M, Tapon-Bretaudi\u00e8re J (2007) Source of tissue factor leading to discrepant plasma FVII levels in eight FVII-deficient patients of African origin. J Thromb Haemost, 5, no. Suppl. 2"},{"key":"7059_CR40","unstructured":"M. Kuppuswamy, A. Sabharwal, J. Birktoft, and S. Bajaj, Molecular characterization of human factor-VII Kansas (gk704)-substitution of Gln100 by Arg in one allele and of Arg304 by Gln possibly in the other allele, in THROMBOSIS AND HAEMOSTASIS, 1993, vol. 69, no. 6: FK SCHATTAUER VERLAG GMBH PO BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART \u2026 pp. 1292\u20131292"},{"issue":"2","key":"7059_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/(SICI)1098-1004(1996)8:2<108::AID-HUMU2>3.0.CO;2-7","volume":"8","author":"F Bernardi","year":"1996","unstructured":"Bernardi F et al (1996) Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mutat 8(2):108\u2013115","journal-title":"Hum Mutat"},{"issue":"1","key":"7059_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14740\/jh943","volume":"11","author":"CA Gallardo","year":"2022","unstructured":"Gallardo CA, Wong LJL, Sum CLL, Goh LL, Ong KH (2022) Compound Heterozygous Factor VII Deficiency c. 1025G\u2009>\u2009A p.(Arg342Gln) With Novel Missense Variant c. 194C\u2009>\u2009G p.(Ala65Gly). J Hematol 11(1):29","journal-title":"J Hematol"},{"key":"7059_CR43","unstructured":"Girolami A, Dal Bo Zanon R, Caenazzo A, Scattolo N (1983) Report of the fifth homozygous patient with factor VII Padua defect, Folia Haematologica (Leipzig, Germany: 1928). 110(3):447\u2013454"},{"issue":"1","key":"7059_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000207528","volume":"62","author":"A Girolami","year":"1979","unstructured":"Girolami A, Patrassi G, Cappellato G, Casonato A (1979) Another family with the factor VII padua clotting defect. Acta Haematol Article vol 62(1):4\u201311. https:\/\/doi.org\/10.1159\/000207528","journal-title":"Acta Haematol Article vol"},{"key":"7059_CR45","doi-asserted-by":"crossref","unstructured":"Tidd TM, Ptashkin B, Pollak ES (2005) Asymptomatic factor VII Padua in African Americans, Blood. 106,(11):98B-98B [Online]. Available: :\/\/WOS:000233426100368.","DOI":"10.1182\/blood.V106.11.4069.4069"},{"key":"7059_CR46","doi-asserted-by":"crossref","unstructured":"Girolami A et al (1993) First report of combined factor VII Padua defect and von Willebrand\u2019s disease due to casual association of the two defects, (in eng), Blood Coagul Fibrinolysis. 4(1): 177\u2009\u2013\u200981","DOI":"10.1097\/00001721-199302000-00031"},{"key":"7059_CR47","doi-asserted-by":"crossref","unstructured":"James HL, Girolami A, Hubbard JG, Kumar A, Fair DS (1993) The dysfunction of coagulation factor VIIPadua results from substitution of arginine-304 by glutamine, Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression. 1172(3):301\u2013305","DOI":"10.1016\/0167-4781(93)90217-2"},{"issue":"1","key":"7059_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MBC.0b013e328331e708","volume":"21","author":"D Kirkel","year":"2010","unstructured":"Kirkel D et al (2010) Asymptomatic factor VII deficiency: gene analysis and structure\u2013function relationships. Blood Coagul Fibrinolysis 21(1):91\u201394","journal-title":"Blood Coagul Fibrinolysis"},{"key":"7059_CR49","unstructured":"Takamiya MI, Kemhell-Cook O, Tuddenham G (1993) E:, Dysfunctional human FVII variants and single-strand conformational polymorphism (SSC5) (abstract). Thromb Hemost ; 69(suppl):1291"},{"issue":"6","key":"7059_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/1098-1004(200006)15:6<489::AID-HUMU1>3.0.CO;2-J","volume":"15","author":"K Wulff","year":"2000","unstructured":"Wulff K, Herrmann FH (2000) Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 15(6):489\u2013496. https:\/\/doi.org\/10.1002\/1098-1004(200006)15:6%3C489::AID-HUMU1%3E3.0.CO;2-J","journal-title":"Hum Mutat"},{"key":"7059_CR51","doi-asserted-by":"publisher","unstructured":"Ahmadi SE et al (2023) Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer, (in eng), Biomark Res.\u00a011(1):60\u00a0https:\/\/doi.org\/10.1186\/s40364-023-00504-6","DOI":"10.1186\/s40364-023-00504-6"},{"issue":"4","key":"7059_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000321534","volume":"124","author":"A Girolami","year":"2010","unstructured":"Girolami A, Berti de Marinis G, Bonamigo E, Sartori R, Vettore S (2010) Ox brain versus rabbit brain thromboplastin assays are the best tool for a preliminary diagnosis of the Arg304Gln factor VII defect (FVII Padua). Acta Haematol 124(4):229\u2013234","journal-title":"Acta Haematol"},{"key":"7059_CR53","doi-asserted-by":"crossref","unstructured":"Mariani G et al (2003) Thrombosis in inherited factor VII deficiency. J Thromb Haemost 1(10):2153\u20132158","DOI":"10.1046\/j.1538-7836.2003.00395.x"},{"key":"7059_CR54","doi-asserted-by":"publisher","unstructured":"Brook R et al Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes. J Thromb Thrombolysis, 58, 3, pp. 391\u2013400, 2025\/03\/01 2025, https:\/\/doi.org\/10.1007\/s11239-025-03077-3","DOI":"10.1007\/s11239-025-03077-3"},{"key":"7059_CR55","doi-asserted-by":"publisher","unstructured":"Winckers K, ten Cate H, Hackeng TM The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev, 27, 3, pp. 119\u2013132, 2013\/05\/01\/ 2013, doi: https:\/\/doi.org\/10.1016\/j.blre.2013.03.001","DOI":"10.1016\/j.blre.2013.03.001"},{"key":"7059_CR56","doi-asserted-by":"publisher","unstructured":"Miyawaki Y et al (Jun 21 2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance, (in eng). N Engl J Med 366(25):2390\u20132396. https:\/\/doi.org\/10.1056\/NEJMoa1201994","DOI":"10.1056\/NEJMoa1201994"},{"key":"7059_CR57","doi-asserted-by":"crossref","unstructured":"Giansily-Blaizot M, Marty S, Chen S-WW, Pellequer J-L, Schved J-F (2012) Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous? Thromb Res, 130, pp. S47-S49","DOI":"10.1016\/j.thromres.2012.08.273"},{"issue":"2","key":"7059_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0609.2010.01544.x","volume":"86","author":"A Girolami","year":"2011","unstructured":"Girolami A, Berti de Marinis G, Bonamigo E, Allemand E (2011) Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua). Eur J Haematol 86(2):135\u2013139","journal-title":"Eur J Haematol"},{"key":"7059_CR59","doi-asserted-by":"crossref","unstructured":"Girolami A, Scarparo P, Bonamigo E, Treleani M, Lombardi A (2012) Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin, Hematology.\u00a017(6):350\u2013354","DOI":"10.1179\/1024533212Z.000000000144"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07059-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:02:19Z","timestamp":1783976539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7059"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07059-0","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}